TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $60,951,000 | +31.7% | 4,256,356 | +25.4% | 0.03% | +33.3% |
| Q4 2021 | $46,277,000 | -29.4% | 3,395,238 | -15.2% | 0.02% | -35.1% |
| Q3 2021 | $65,572,000 | +3.3% | 4,003,155 | +6.1% | 0.04% | +2.8% |
| Q2 2021 | $63,492,000 | -9.4% | 3,772,537 | -1.7% | 0.04% | -10.0% |
| Q1 2021 | $70,069,000 | +9.4% | 3,837,294 | +9.1% | 0.04% | 0.0% |
| Q4 2020 | $64,030,000 | +0.4% | 3,518,126 | -1.6% | 0.04% | -13.0% |
| Q3 2020 | $63,787,000 | +1.8% | 3,575,505 | +2.3% | 0.05% | -4.2% |
| Q2 2020 | $62,651,000 | +22.3% | 3,494,212 | +3.6% | 0.05% | +2.1% |
| Q1 2020 | $51,210,000 | -25.8% | 3,373,517 | -3.6% | 0.05% | -6.0% |
| Q4 2019 | $69,055,000 | +27.1% | 3,499,987 | +10.8% | 0.05% | +13.6% |
| Q3 2019 | $54,333,000 | +11.7% | 3,158,924 | +15.0% | 0.04% | +10.0% |
| Q2 2019 | $48,632,000 | -27.9% | 2,747,586 | -17.1% | 0.04% | -31.0% |
| Q1 2019 | $67,486,000 | +160.2% | 3,312,996 | +114.9% | 0.06% | +123.1% |
| Q4 2018 | $25,936,000 | -38.4% | 1,541,957 | -21.8% | 0.03% | -29.7% |
| Q3 2018 | $42,131,000 | +16.5% | 1,971,498 | +14.0% | 0.04% | +8.8% |
| Q2 2018 | $36,153,000 | -17.3% | 1,729,785 | -3.5% | 0.03% | -20.9% |
| Q1 2018 | $43,737,000 | -0.9% | 1,791,765 | +15.5% | 0.04% | -2.3% |
| Q4 2017 | $44,134,000 | +24.4% | 1,551,288 | +21.1% | 0.04% | +12.8% |
| Q3 2017 | $35,467,000 | +48.7% | 1,280,857 | +36.5% | 0.04% | +34.5% |
| Q2 2017 | $23,850,000 | +25.6% | 938,237 | +16.8% | 0.03% | 0.0% |
| Q1 2017 | $18,989,000 | +92.9% | 803,435 | +69.6% | 0.03% | +107.1% |
| Q4 2016 | $9,843,000 | -12.0% | 473,690 | +1.5% | 0.01% | -17.6% |
| Q3 2016 | $11,183,000 | +54.3% | 466,836 | +38.8% | 0.02% | +54.5% |
| Q2 2016 | $7,246,000 | -48.2% | 336,413 | -45.1% | 0.01% | -52.2% |
| Q1 2016 | $13,984,000 | +23.6% | 612,777 | +35.5% | 0.02% | +21.1% |
| Q4 2015 | $11,316,000 | +35.2% | 452,098 | +30.8% | 0.02% | +18.8% |
| Q2 2015 | $8,371,000 | +12.0% | 345,614 | +15.8% | 0.02% | +6.7% |
| Q1 2015 | $7,475,000 | +56.2% | 298,541 | +29.4% | 0.02% | +50.0% |
| Q4 2014 | $4,786,000 | -13.5% | 230,784 | -9.3% | 0.01% | -16.7% |
| Q3 2014 | $5,531,000 | -4.5% | 254,425 | +2.1% | 0.01% | -7.7% |
| Q2 2014 | $5,793,000 | -1.1% | 249,161 | +0.8% | 0.01% | -7.1% |
| Q1 2014 | $5,859,000 | +5.7% | 247,212 | +2.6% | 0.01% | +7.7% |
| Q4 2013 | $5,545,000 | +7.0% | 240,863 | +10.3% | 0.01% | -7.1% |
| Q3 2013 | $5,181,000 | +20.3% | 218,423 | +14.5% | 0.01% | +7.7% |
| Q2 2013 | $4,307,000 | – | 190,724 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |